glp-1 papillary thyroid cancer Does Using Drugs, Like Zepbound or Wegovy, Increase Your Risk of Cancer? Letter: Association Between Incretin Mimetics

Often yes, but not for everyone

Ozempic, another semaglutide product, saw a 30% increase, while even the older Victoza (liraglutide) grew by 21%, driven by a 113% surge in North American demand

Complete a short medical quiz to help the physician learn more about your health

It chimes with a peer-reviewed study from Cornell University, external published last year, which found that US households with at least one member using weight-loss drugs spent 5% less on groceries within six months of starting the medication, with that rising to 8% among higher income families

Available online: [Google Scholar] 21.Caricilli A.M., Penteado E., de Abreu L.L., Quaresma P.G., Santos A.C., Guadagnini D., Razolli D., Mittestainer F.C., Carvalheira J.B., Velloso L.A., et al